Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 330

1.

Toward integrative cancer immunotherapy: targeting the tumor microenvironment.

Emens LA, Silverstein SC, Khleif S, Marincola FM, Galon J.

J Transl Med. 2012 Apr 10;10:70. doi: 10.1186/1479-5876-10-70.

2.

Oncology meets immunology: the cancer-immunity cycle.

Chen DS, Mellman I.

Immunity. 2013 Jul 25;39(1):1-10. doi: 10.1016/j.immuni.2013.07.012. Review.

3.

Targeting the tumor microenvironment by immunotherapy: part 2.

Leibovici J, Itzhaki O, Huszar M, Sinai J.

Immunotherapy. 2011 Nov;3(11):1385-408. doi: 10.2217/imt.11.112. Review.

PMID:
22053888
4.

The immune score as a new possible approach for the classification of cancer.

Galon J, Pagès F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA.

J Transl Med. 2012 Jan 3;10:1. doi: 10.1186/1479-5876-10-1.

5.

Shaping of an effective immune microenvironment to and by cancer cells.

Becht E, Goc J, Germain C, Giraldo NA, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH.

Cancer Immunol Immunother. 2014 Oct;63(10):991-7. doi: 10.1007/s00262-014-1590-3. Epub 2014 Aug 12. Review.

PMID:
25112529
6.

Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.

Balwit JM, Kalinski P, Sondak VK, Coulie PG, Jaffee EM, Gajewski TF, Marincola FM.

J Transl Med. 2011 May 12;9:60. doi: 10.1186/1479-5876-9-60.

7.

Cancer immunologists and cancer biologists: why we didn't talk then but need to now.

Prendergast GC, Jaffee EM.

Cancer Res. 2007 Apr 15;67(8):3500-4. Epub 2007 Apr 5.

8.

The tumor microenvironment: part 1.

Leibovici J, Itzhaki O, Huszar M, Sinai J.

Immunotherapy. 2011 Nov;3(11):1367-84. doi: 10.2217/imt.11.111. Review.

PMID:
22053887
9.

[Immune response and cancer].

El Hage F, Abouzahr-Rifai S, Meslin F, Mami-Chouaib F, Chouaib S.

Bull Cancer. 2008 Jan;95(1):57-67. doi: 10.1684/bdc.2008.0558. Review. French.

10.

Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.

Gajewski TF, Woo SR, Zha Y, Spaapen R, Zheng Y, Corrales L, Spranger S.

Curr Opin Immunol. 2013 Apr;25(2):268-76. doi: 10.1016/j.coi.2013.02.009. Epub 2013 Apr 8. Review.

PMID:
23579075
11.

Regulation of the anti-tumour immune response by cancer-associated fibroblasts.

Harper J, Sainson RC.

Semin Cancer Biol. 2014 Apr;25:69-77. doi: 10.1016/j.semcancer.2013.12.005. Epub 2014 Jan 7. Review.

PMID:
24406209
12.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
13.

Mast cells as targets for immunotherapy of solid tumors.

Oldford SA, Marshall JS.

Mol Immunol. 2015 Jan;63(1):113-24. doi: 10.1016/j.molimm.2014.02.020. Epub 2014 Mar 31. Review.

14.

The inflammatory tumor microenvironment and its impact on cancer development.

de Visser KE, Coussens LM.

Contrib Microbiol. 2006;13:118-37. Review.

PMID:
16627962
15.

Modification of the tumor microenvironment to enhance immunity.

Liao YP, Schaue D, McBride WH.

Front Biosci. 2007 May 1;12:3576-600. Review.

PMID:
17485323
16.

Targeting the tumor microenvironment for cancer therapy.

Sounni NE, Noel A.

Clin Chem. 2013 Jan;59(1):85-93. doi: 10.1373/clinchem.2012.185363. Epub 2012 Nov 28. Review.

17.

The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program.

Balwit JM, Hwu P, Urba WJ, Marincola FM.

J Transl Med. 2011 Jan 31;9:18. doi: 10.1186/1479-5876-9-18. Review.

18.

[Development of novel immunotherapy targeting cancer immune evasion].

Tamada K.

Gan To Kagaku Ryoho. 2014 Sep;41(9):1062-5. Japanese.

PMID:
25248888
20.

T cell recognition of human tumors: implications for molecular immunotherapy of cancer.

Ioannides CG, Whiteside TL.

Clin Immunol Immunopathol. 1993 Feb;66(2):91-106. Review.

PMID:
8453790

Supplemental Content

Support Center